A detailed history of Israel Englander (Millennium Management LLC) transactions in Haemonetics Corp stock. As of the latest transaction made, Millennium Management LLC holds 245,676 shares of HAE stock, worth $19.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
245,676
Previous 102,787 139.01%
Holding current value
$19.4 Million
Previous $8.5 Million 132.2%
% of portfolio
0.01%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.45 - $91.58 $10.4 Million - $13.1 Million
142,889 Added 139.01%
245,676 $19.7 Million
Q2 2024

Aug 14, 2024

SELL
$81.24 - $97.37 $18.1 Million - $21.7 Million
-223,211 Reduced 68.47%
102,787 $8.5 Million
Q1 2024

May 15, 2024

BUY
$71.24 - $85.35 $12.9 Million - $15.5 Million
181,290 Added 125.28%
325,998 $27.8 Million
Q4 2023

Feb 14, 2024

BUY
$80.59 - $92.61 $8.96 Million - $10.3 Million
111,156 Added 331.29%
144,708 $12.4 Million
Q2 2023

Aug 14, 2023

BUY
$80.84 - $89.45 $1.67 Million - $1.85 Million
20,670 Added 160.46%
33,552 $2.86 Million
Q1 2023

May 15, 2023

SELL
$72.75 - $90.6 $30.4 Million - $37.8 Million
-417,218 Reduced 97.0%
12,882 $1.07 Million
Q4 2022

Feb 14, 2023

SELL
$73.85 - $86.14 $23.1 Million - $27 Million
-313,408 Reduced 42.15%
430,100 $33.8 Million
Q3 2022

Nov 14, 2022

BUY
$63.3 - $78.66 $25.6 Million - $31.8 Million
404,582 Added 119.37%
743,508 $55 Million
Q2 2022

Aug 15, 2022

BUY
$49.27 - $66.08 $15.7 Million - $21 Million
318,014 Added 1520.72%
338,926 $22.1 Million
Q1 2022

May 16, 2022

SELL
$43.77 - $63.22 $8.2 Million - $11.8 Million
-187,437 Reduced 89.96%
20,912 $1.32 Million
Q4 2021

Feb 14, 2022

SELL
$49.55 - $74.59 $29.7 Million - $44.7 Million
-598,903 Reduced 74.19%
208,349 $11.1 Million
Q3 2021

Nov 15, 2021

BUY
$57.6 - $70.59 $10.9 Million - $13.3 Million
188,868 Added 30.54%
807,252 $57 Million
Q2 2021

Aug 16, 2021

BUY
$51.81 - $118.56 $13.2 Million - $30.2 Million
254,325 Added 69.86%
618,384 $41.2 Million
Q1 2021

May 17, 2021

BUY
$111.01 - $139.48 $8.17 Million - $10.3 Million
73,634 Added 25.35%
364,059 $40.4 Million
Q4 2020

Feb 16, 2021

BUY
$88.75 - $119.95 $1.32 Million - $1.79 Million
14,929 Added 5.42%
290,425 $34.5 Million
Q3 2020

Nov 16, 2020

SELL
$75.65 - $93.58 $865,738 - $1.07 Million
-11,444 Reduced 3.99%
275,496 $24 Million
Q2 2020

Aug 14, 2020

BUY
$84.96 - $118.91 $22.1 Million - $30.9 Million
260,119 Added 969.83%
286,940 $25.7 Million
Q1 2020

May 14, 2020

SELL
$74.34 - $121.82 $3.12 Million - $5.11 Million
-41,941 Reduced 60.99%
26,821 $2.67 Million
Q4 2019

Feb 14, 2020

SELL
$114.37 - $129.46 $10.4 Million - $11.8 Million
-90,897 Reduced 56.93%
68,762 $7.9 Million
Q3 2019

Nov 14, 2019

BUY
$117.16 - $138.52 $12.7 Million - $15.1 Million
108,707 Added 213.35%
159,659 $20.1 Million
Q2 2019

Aug 15, 2019

SELL
$81.74 - $120.34 $4.56 Million - $6.72 Million
-55,840 Reduced 52.29%
50,952 $6.13 Million
Q2 2019

Aug 14, 2019

BUY
$81.74 - $120.34 $7.88 Million - $11.6 Million
96,373 Added 924.97%
106,792 $21.8 Million
Q1 2019

May 14, 2019

BUY
$83.25 - $102.12 $867,381 - $1.06 Million
10,419 New
10,419 $911,000
Q4 2018

Feb 14, 2019

SELL
$90.66 - $116.63 $11.4 Million - $14.7 Million
-125,792 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$89.96 - $114.58 $9.37 Million - $11.9 Million
-104,157 Reduced 45.3%
125,792 $14.4 Million
Q2 2018

Aug 14, 2018

SELL
$71.53 - $95.75 $68.2 Million - $91.3 Million
-953,595 Reduced 80.57%
229,949 $20.6 Million
Q1 2018

May 15, 2018

BUY
$60.72 - $74.41 $68 Million - $83.3 Million
1,120,115 Added 1765.94%
1,183,544 $86.6 Million
Q4 2017

Feb 14, 2018

SELL
$44.96 - $58.99 $10.9 Million - $14.4 Million
-243,395 Reduced 79.33%
63,429 $3.68 Million
Q3 2017

Nov 14, 2017

BUY
$40.38 - $44.87 $12.4 Million - $13.8 Million
306,824
306,824 $13.8 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.04B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.